However, various ligands had been discovered to work in conjunction with diverse GPCRs to activate YAP/TAZ to cause different diseases through the induction of Rho GTPases, including organ fibrosis, oral squamous cell carcinoma, and hepatocellular carcinoma (HCC).34, 43, 44, 45. Here, YAP1 is linked to hepatocellular carcinoma.